MTND5P15

Across TCGA pan-cancer cohorts, MTND5P15 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTND5P15 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTND5P15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND5P15 expression acts as an unfavorable survival marker, although some lineages such as READ and LAML show a favorable association.

UCEC, BLCA, and THCA are the cancer types where MTND5P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.857	0.940	<.001	96	view →
BLCA	OS	Tertile	IV	0.285	0.511	.001	50	view →
THCA	OS	Tertile	III,IV	0.311	0.912	.001	45	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	36	view →
READ	DFS	Tertile	All	0.930	0.453	.024	21	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →
LUAD	OS	Tertile	IV	0.474	0.738	.044	18	view →
KIRC	DFS	Median	IV	0.204	0.397	.013	15	view →
DLBC	OS	Quartile	III,IV	0.499	0.955	.016	14	view →
KICH	DFS	Quartile	II,III,IV	0.294	0.831	.020	13	view →
COAD	DFS	Tertile	III,IV	0.178	0.588	.001	9	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTND5P15–UCEC (OS)

Open the UCEC breakdown →